HSPA5 and cancer: Towards that goal and fast-tracking to the clinic, we recently reported a high-throughput screen of clinically relevant compound libraries yielding a surprising result that many of the top hits belonged to a class of compounds referred to as cardiac glycosides (CGs) and they could inhibit ER-stress induction of GRP78 in a variety of human cancers [33].